Napo Therapeutics, S.p.A.: Clinical Trials

1 trial sponsored by Napo Therapeutics, S.p.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Napo Therapeutics, S.p.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution - Short Bowel Syndrome, Malabsorption Syndromes
Phase 2RecruitingNapo Therapeutics, S.p.A.182025-05-292026-06-09

Conditions studied

Gastrointestinal Diseases (1)  ·  Malabsorption Syndromes (1)  ·  Postoperative Complications (1)  ·  Short Bowel Syndrome (1)

Interventions

Solutions (1)

Countries

Germany (1)  ·  Italy (1)